Skip to main content
Premium Trial:

Request an Annual Quote

BioWisdom Joins $14.5M European Alzheimer Biomarker Project

NEW YORK, May 4 (GenomeWeb News) - Cambridge, UK-based BioWisdom said today that it will join the AddNeuroMed project of the European Commission's Innovative Medicines for Europe consortium, where it will use its Sofia software platform to help identify and validate Alzheimer's disease biomarkers.
 
BioWisdom said it will receive direct funding for its work, but it did not disclose financial details.
 
The INNOMED consortium of about 40 commercial and academic groups is led by the European Federation of Pharmaceutical Industries and Associations.
 
The consortium is sponsored by the EC under its Sixth Framework Program, which will provide about €11.5 million ($14.5 million) over three years, the statement added.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.